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Edited by Felix WielandAbstract A high-precision solution structure of the C-terminal
minicollagen cysteine rich domain of Hydra has been determined
using modern heteronuclear and weak alignment NMR tech-
niques at natural isotope abundance. The domain consists of only
24 amino acids, six of which are prolines and six are cysteines
bonded in disulﬁde bridges that constrain the structure into a new
fold. The redox equilibrium of the structure has been character-
ized from a titration with glutathione. No local native structures
are detectable in the reduced form. Thus, oxidation and folding
are tightly coupled.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Minicollagens from Hydra are the smallest known collagens
to date [1]. They are found in the walls of nematocysts, which
are explosive organelles formed from a post-Golgi vesicle in
Hydra, jellyﬁsh, corals and other Cnidaria. The explosive dis-
charge of nematocysts is a specialized exocytosis process which
achieves accelerations of >40 000 g and is one of the fastest
natural processes [2]. This process is enabled by an estimated
intramolecular osmotic pressure of 150 bar, which results from
an enrichment of poly-c-glutamate in the capsule matrix dur-
ing maturation [3].
Nematocyst walls are stabilized by a collageneous matrix
[4], which depends on disulﬁde crosslinking [5] to withstand
the extreme osmotic pressure. The Hydra capsule wall mainly
consists of the proteins minicollagen and NOWA [6–8] (Fig.
1). Both proteins contain highly homologous cysteine- and
proline-rich domains, henceforward called minicollagen cys-
teine rich domains (MCRDs) [9]. Minicollagens are expressed
as soluble precursor forms with intramolecular disulﬁde
bonds in their MCRDs [6,8]. In nematocyst development a
wall hardening occurs, during which the intramolecular* Corresponding author. Fax: +41-61-267-2109.
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molecular bonds, thereby crosslinking molecules within the
capsule wall [6]. The simultaneous appearance of MCRDs in
minicollagen and NOWA points to a concerted function in
wall hardening. A more detailed comparison and discussion
of the biological context is given in an accompanying paper
[10].
Here, we report the NMR determination of the solution
structure of the C-terminal MCRD domain of minicollagen 1.
The domain consists of only 24 amino acids, six of which are
cysteines and six are prolines. The well-deﬁned structure forms
in high yields within 2 h when disulﬁde bond formation is
catalyzed by glutathione. No local native structures are de-
tectable in the reduced form of the MCRD. Thus, oxidation
and folding are tightly coupled.2. Materials and methods
The MCRD Minicol1C (Fig. 1, underlined) was chemically synthe-
sized without isotope enrichment and puriﬁed after oxidation as de-
scribed elsewhere [10]. NMR samples were prepared to 5 mM peptide
concentration in 5 mM phosphate, 2 mM NaN3, 95% H2O/5% D2O,
and pH 6.5. A 2 mM NMR sample of identical pH and ionic strength
was lyophilized and redissolved in D2O. For the measurement of re-
sidual dipolar couplings (RDCs), a 3 mM peptide sample was prepared
in 10 mg/ml Pf1 phage solution (Asla Biotech) with 5 mM phosphate
of pH 6.5 and 350 mM NaCl to tune down electrostatic interactions of
the positively charged MCRD (pI 8.74) with the phages [11], resulting
in a maximal coupling ANHzz ¼ 11.5 Hz.
2.1. NMR spectroscopy
All multidimensional NMR measurements were performed at 15 C
on Bruker DRX 600 and 800 spectrometers. 1H, 13C and 15N assign-
ments were obtained from TOCSY, NOESY as well as 15N and 13C
natural abundance HSQC and HMBC spectra. 1DHN and
1DCH RDCs
were obtained by non-decoupled HSQCs. Spectra were processed with
NMRPipe [12] and analyzed with PIPP [13].
2.2. Structure determination
In addition to NOEs, the input for the structure calculations con-
tained backbone 1DHN, backbone and sidechain
1DCH RDCs as well as
dihedral angle restraints obtained with TALOS [14] (Table 1). All ﬁve
X-Pro peptide groups were found to be in trans conformation by
speciﬁc, strong sequential dad NOEs. Structures were calculated in
CNS [15] with a simulated annealing protocol using RDCs without a
priori knowledge of the orientation tensor via the ISAC routine [16].
Structure representations were generated by MOLMOL [17].blished by Elsevier B.V. All rights reserved.
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Fig. 1. Top: Domain organization of Hydra minicollagen 1 and
NOWA. MCRDs are indicated as circles. Bottom: sequence alignment
of minicollagen and NOWA MCRDs. For simplicity, residues of the
Minicol1C MCRD used in this study are renumbered from 1 to 24.
Table 1
Statistics of the MCRD NMR structurea
RMSDs from experimental distance
constraints [A] all (331)b
0.044 0.001
RMSDs from dipolar coupling
constraints (37)c
1.2 Hz
NMR quality factor Qd 0.20
RMSDs from dihedral constraints [] (15)e 0.83 0.03
Deviation from the idealized covalent geometry
Bonds [A] 0.0053 0.0002
Angles [] 0.74 0.01
Impropersf [] 0.72 0.01
Coordinate precision [A]g
Backbone non-hydrogen atoms 0.16
All non-hydrogen atoms 0.56
Percentage of non-gly, non-pro residues in
Ramachandran regionsh
Core 93.3
Allowed 6.7
Generous 0.0
Disallowed 0.0
a The statistics were obtained from a subset of the 10 lowest energy
structures out of 100 calculated with a CNS [15] simulated annealing
protocol using dipolar restraints implemented in the form of the ISAC
routine [16]. The number of constraints is given in parentheses. Co-
ordinate precision and Ramachandran plot quality are reported for the
core of the structure (residues 2–21) excluding the ﬂexible N- and C-
terminus.
bNOEs comprise 60 intraresidual NOEs, 132 sequential NOEs
ðji jj ¼ 1Þ, 114 short range NOEs ð1 < ji jj6 5Þ and 25 long range
NOEs ðji jj > 5Þ. Hydrogen bond constraints were not imposed.
cRDC data comprise 13 1H–15N, 18 1H–13Ca and 6 sidechain 1H–13C
methyl and methine dipolar one-bond couplings. Only RDCs of the
non-ﬂexible MCRD core residues are incorporated.
d The NMR quality factor Q is deﬁned as the ratio of the rmsd between
observed and calculated couplings and the rms of the observed cou-
plings [27].
e The dihedral angle constraints comprise 4/ and 9w obtained for
residues 2–21 with 1H, 15N and 13C natural abundance chemical shift
assignments as inputs for TALOS [14], as well as 2v1 angles obtained
from NOESY peak intensities for two residues with very few long-
range NOE data (Cys2 in a PCPP sequence and solvent exposed Gln9).
f The improper torsion angle restraints serve to maintain planarity and
chirality.
g The coordinate precision is deﬁned as the average root mean square
distance between the individual simulated annealing structures and the
mean coordinates. Values are reported for core residuesa.
hValues are calculated with the program PROCHECK-NMR [28] for
the residues 2–21a. The inverse c-turn geometry of Cys10 (Fig. 4) is
the only one of these residues to fall outside the core region of the
Ramachandran plot.
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MCRD (0.3 mM) was reduced completely with 6 mM tris(2-carb-
oxyethyl)-phosphine hydrochloride (TCEP) at pH 7.5. Oxidative re-
folding was started by the addition of 40 mM oxidized glutathione
(GSSG) in 5 mM phosphate buﬀer, pH 7.5. Refolding was monitored
by 1D 1H NMR experiments and ﬁtted to monoexponentials with
ProFit (Quantumsoft).
Equilibrium unfolding of 0.3 mM MCRD in 9 mM GSSG, and 100
mM phosphate (pH 7.0, 25 C) was induced by the addition of varying
amounts of reduced glutathione (GSH) in 100 mM phosphate (pH 7.0)
and monitored by 1D 1H NMR after 12 h incubation in airtight Shi-
gemi tubes. Concentrations of GSH and GSSG were validated from
the integrals of the respective 1H NMR spectra.3. Results
3.1. Assignment, structure determination and disulﬁde pattern
of MCRD
Sequence speciﬁc 1H, 13C, and 15N assignments were ob-
tained from TOCSY and NOESY as well as heteronuclear
HSQC and HMBC spectra acquired at natural isotope abun-
dance (Fig. 2). All cysteine residues are bonded in disulﬁde
bridges as evidenced by their 13Cb shifts of 40–43.5 ppm [18].
The homogeneous spectra show only one single protein species
(Fig. 2). All non-labile protons could be assigned for structure
calculations. Water exchange results in broadening of amide
protons of Cys2 and Gln16 (Fig. 2), which is abolished at
lower pH values.
In total, 331 distance constraints were obtained from NO-
ESY spectra in H2O and D2O (Table 1). In addition, 37
1DHN
and 1DCH RDCs for residues 2–21 were measured at natural
isotope abundance in weakly oriented samples and incorpo-
rated in the structure calculations (Fig. 3, Table 1) to further
improve the structural quality. The resulting high resolution
structure with a heavy atom backbone RMSD of 0.16 A as
well as pairwise interresidual dHbiHbk NOEs in all disulﬁde
bonds prove the disulﬁde pattern Cys2–Cys18, Cys6–Cys14
and Cys10–Cys19 (Fig. 4).6.87.07.27.47.67.88.08.28.48.68.89.0
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Fig. 2. Natural abundance 1H–15N HSQC spectrum of Minicol1C
MCRD (5 mM, experimental time 1.5 h). Cys2 is broadened beyond
detection due to solvent exchange but is identiﬁed at pH 4 at the in-
dicated position.
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Fig. 3. Top: 1D traces of heteronuclear natural abundance spectra for
the measurement of RDCs. Bottom: comparison of measured RDCs
and RDCs derived from the calculated average structure of Minicol1C
MCRD.
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preceding polyproline II helix in minicollagen 1 and adopts
ð/=wÞ-values of ()60 to )90/125–155) similar to confor-
mations in the ideal PPII helix ()75/145). The subsequent
short a-helix (residues 4–8) is followed by an inverse c-turn
(9–11), a type I b-turn (11–14) and a type III b-turn (15–18).
The highly conserved Pro12 stabilizes the bI turn topology as
canonical residue iþ 1. The structure of MCRD (including the
helix) can be viewed as a consecutive arrangement of turns,
where each turn contains one cysteine that is directed away
from the turn to form the aforementioned long-range disulﬁde
pattern.
Backbone HN!O0 hydrogen bonds in the turns from resi-
dues 6! 3, 8c4, 9! 5, 11! 9, 14! 11, 18! 15 are evident
from the structure, deviations from random coil 1HN chemical
shifts (Fig. 2) and reduced 1H/2H exchange. A schematic over-
view of turns, hydrogen bonds and disulﬁde bridges is shown in
Fig. 4.
A three-dimensional similarity search of the PDB with the
program DALI [19] did not yield any related structures. ThisFig. 4. The structure of Minicol1C MCRD. Left: stereo view in an all-heav
structures calculated. The backbone is displayed in dark orange and sidech
terminal sequence K22R23K24 is disordered at pH 6.5 in the absence of additio
view shows that disulﬁde bonds Cys10–Cys19 and Cys2–Cys18 are solvent ac
Right: disulﬁde and hydrogen bond topology.indicates that the MCRD motif represents a new fold, re-
ﬂecting its highly specialized function in the disulﬁde-mediated
crosslinking of the nematocyst wall. It should also be noted
that MCRD with six cysteines in a folded core of only 20
structured amino acids represents one of the sequences with
the highest densities of disulﬁde bonds known so far [10].
1HN T2 relaxation times >120 ms of 2 mM MCRD at 25 C
show that MCRD is a monomer in solution and therefore
should not contribute to the non-covalent stabilization of the
minicollagen trimer by intermolecular interactions. Accord-
ingly, the reduction of the MCRD disulﬁde bonds was found
to have no inﬂuence on the transition temperature of 45 C for
minicollagen 1 trimerization [8].
3.2. Reductive unfolding and oxidative refolding
MCRD is readily reduced by an excess of TCEP or gluta-
thione at pH 7.5. Upon reduction, all hydrogen bonds in the
turns are abolished as evident from a change of amide 1HN
resonance shifts to random coil values of >7.9 ppm for all
residues (Fig. 5A). NOESY spectra give additional evidence
that the structure is largely in extended or in random coil
conformation, as the strong dHNHN NOEs of the turns are
abolished. Moreover, the 15N resonance of Thr13 assumes a
random coil value (114.3 ppm), whereas position iþ 2 of a bI
turn usually has characteristic 15N upﬁeld shifts [14] (103.7
ppm in the native MCRD structure, Fig. 2). Thus, the disulﬁde
pattern in MCRD obviously does not result from a non-
covalently folded precursor, in which cysteines are already
properly preoriented. Rather oxidation and folding occur si-
multaneously, and the disulﬁde bonds stabilize the natively
folded structure.
Oxidative folding of completely reduced MCRD was started
by the addition of a >100-fold excess of oxidized glutathione
as its natural oxidant. Refolding was easily monitored by 1D
NMR spectra of upﬁeld shifted 1HN turn resonances (Fig. 5A)
which do not overlap with the glutathione signal. The 1D
signals apparently correspond either to the native folded spe-
cies or a single unfolded state, whereas other intermediates are
not highly populated. Folding proceeds to a steady state within
about 2 h (Fig. 5A). Fitting of signal intensities to monoex-
ponentials shows a decay rate of 1.13 0.06 h1 for resonances
corresponding to the unfolded species, whereas the native
signals are formed at a slightly slower rate of 0.78 0.03 h1y-atom representation of the 10 lowest energy conformers out of 100
ains in cyan, except for cysteine sidechains in yellow. The charged C-
nal salt. Center: ribbon representation in the same orientation as stereo
cessible, whereas the central disulﬁde bond Cys6–Cys14 is inaccessible.
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Fig. 5. Oxidative folding and reductive unfolding of MCRD. (A) 1D
spectra of MCRD folding initiated by addition of 40 mM GSSG to 0.3
mM MCRD previously reduced with TCEP. Spectra were recorded at
the indicated times after starting the oxidation reaction. Backbone
1HN (plain numbers) and sidechain resonances are indicated. (B) Time
course of glutathione catalyzed refolding as monitored by the indicated
resonance intensities derived from the spectra in (A). (C) Hill plot of
equilibrium reductive unfolding monitored in a solution of varying
GSH/GSSG content (see text). Solid lines correspond to linear ﬁts of
the low and high [GSH]2/[GSSH] regions of the correlation.
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intermediate, where for example a non-random coil and non-
native oxidized ensemble rearranges slowly to the native oxi-
dized state [20].
In order to obtain information on the redox potentials of the
disulﬁdes, equilibrium unfolding of MCRD was studied by a
titration of the ratio of reduced (GSH) versus oxidized (GSSG)
glutathione [21]. The ratio of reduced versus oxidized MCRD,
[MCRDred]/[MCRDox], was obtained from an integration of the
corresponding 1D 1HN and 1Hd resonances of threonine-13 and
tyrosine-17, respectively (Fig. 5C). Assuming that the loss of thefolded oxidized structure is caused by the cooperative reduction
of n disulﬁde bridges, the reaction can be described byMCRDox þ nGSSG $MCRDred þ nð2GSHÞ
corresponding to an equilibrium of the form Keq ¼
½MCRDred=½MCRDox  ð½GSH2=½GSSHÞn [21]. The cooper-
ativity n can be obtained from the slope of a Hill plot of
log([MCRDred]/[MCRDox]) vs. log([GSH]
2/[GSSH]) as shown
in Fig. 5C. The transition from the folded, oxidized to the
unfolded, reduced form is non-cooperative ðn ¼ 0:92Þ at low
[GSH]2/[GSSG] (<100 mM), whereas it becomes more coop-
erative ðn ¼ 2:5Þ at higher [GSH]2/[GSSG] ratios. This can
be explained by a model where at low reducing potential only
one disulﬁde opens, whereas for stronger reducing potentials
all three disulﬁdes open. Apparently, the opening of the ﬁrst
disulﬁde is suﬃcient to account for the signal loss of the
folded resonances. The midpoint of the redox reaction
([MCRDox]/[MCRDred]¼ 1) is found at a [GSH]2/[GSSH]
ratio of 30 mM. This corresponds to an apparent, eﬀective
redox potential E00(MCRD) of )185 mV, where the Nernst
relation E00ðMCRDÞ ¼ E00ðglutathioneÞ  RT=2F lnð½GSH2=
½GSSHÞmidpoint and a standard redox potential for glutathione
E00(glutathione) of )230 mV at 25 C [22] have been used.
Judging from this eﬀective equilibrium constant, MCRD
should be predominantly folded with all disulﬁde bonds intact
at physiological concentrations of GSH and GSSG in micro-
somes ([GSH]2/[GSSG]< 3 mM [23,24]).4. Discussion
The MCRD domain adopts a new fold that is highly deﬁned
by its three disulﬁde bridges. This structure arises during oxi-
dative folding without populating other structured intermedi-
ates to high concentrations. The repeating cysteine pattern
CXXXC in MCRD with three intervening residues between
the cysteines has been shown to be highly unfavorable for
nearest-neighbor disulﬁde bond formation [25]. Accordingly,
the MCRD structure only contains long-range disulﬁde bonds,
which presumably lock into the native conformation during
oxidative refolding after the formation of the central, non-
accessible disulﬁde bridge Cys6–Cys14. The wealth of proline
residues as well as the formation of hydrogen bonds may re-
strict the conformational search and stabilize local structure in
MCRD during this folding process.
The structure of oxidized MCRD is not unfolded in 8 M
urea as evident from 1H NMR spectra (data not shown),
whereas even local structures are abolished by reduction. This
underlines the high importance of the disulﬁde bonds relative
to hydrophobic interactions in stabilizing the fold and local
native structures. In consequence the cysteine pattern, but not
the hydrophobic residues of MCRD domains, is highly con-
served [7].
The MCRD domain fulﬁlls its biological role by intermo-
lecular disulﬁde bond reshuﬄing [7]. This process is most likely
catalyzed [26] and probably involves at least one of the two
solvent exposed disulﬁde bridges Cys2–Cys18 and Cys10–
Cys19. Of these, the N-terminal Cys2–Cys18 should be par-
ticularly accessible in the N-terminal MCRDs of minicollagen.
The equilibrium unfolding with the natural reductant GSH
shows the presence of such a single susceptible disulﬁde bond
in MCRD at weakly reducing conditions.
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The atomic coordinates of the 10 lowest energy CNS con-
formers have been deposited in the RCSB Protein Data Bank
(www.rcsb.org) under PDB Accession number 1SP7. Chemical
shift assignments have been deposited in the BioMagResBank
(www.bmrb.wisc.edu) under Accession number 6200.
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